$0.45
12.63% yesterday
Nasdaq, Nov 15, 09:49 pm CET
ISIN
US09074H1041
Symbol
BTCY

Biotricity Inc Stock price

$0.45
+0.19 73.27% 1M
-3.13 87.42% 6M
-3.13 87.42% YTD
-3.13 87.42% 1Y
-3.13 87.42% 3Y
-0.05 9.90% 5Y
-2.20 83.00% 10Y
Nasdaq, Closing price Fri, Nov 15 2024
+0.05 12.63%
ISIN
US09074H1041
Symbol
BTCY

Key metrics

Market capitalization $10.19m
Enterprise Value $35.37m
P/E (TTM) P/E ratio negative
EV/FCF (TTM) EV/FCF negative
EV/Sales (TTM) EV/Sales 2.89
P/S ratio (TTM) P/S ratio 0.83
P/B ratio (TTM) P/B ratio negative
Revenue growth (TTM) Revenue growth 15.47%
Revenue (TTM) Revenue $12.24m
EBIT (operating result TTM) EBIT $-7.63m
Free Cash Flow (TTM) Free Cash Flow $-6.36m
Cash position $100.00k
EPS (TTM) EPS $-1.73
P/S forward 0.77
EV/Sales forward 2.42
Short interest 2.25%
Show more

Is Biotricity Inc a Top Scorer Stock based on the Dividend, High-Growth-Investing or Leverman Strategy?

As a Free StocksGuide user, you can view scores for all 6,897 stocks worldwide.

Biotricity Inc Stock Analysis

Unlock Scores for Free

Analyst Opinions

1 Analyst has issued a forecast Biotricity Inc:

1x Hold
100%

Analyst Opinions

1 Analyst has issued a forecast Biotricity Inc:

Hold
100%

Financial data from Biotricity Inc

Income Statement P&L | Balance Sheet | Cash Flow


Quarter TTM Annually
Jun '24
+/-
%
12 12
15% 15%
100%
- Direct Costs 3.44 3.44
23% 23%
28%
8.80 8.80
44% 44%
72%
- Selling and Administrative Expenses 14 14
13% 13%
113%
- Research and Development Expense 2.37 2.37
24% 24%
19%
-7.34 -7.34
43% 43%
-60%
- Depreciation and Amortization 0.28 0.28
26% 26%
2%
EBIT (Operating Income) EBIT -7.63 -7.63
42% 42%
-62%
Net Profit -14 -14
17% 17%
-117%

In millions USD.

Don't miss a Thing! We will send you all news about Biotricity Inc directly to your mailbox free of charge.

If you wish, we will send you an e-mail every morning with news on stocks of your portfolios.

Biotricity Inc Stock News

Neutral
Seeking Alpha
40 minutes ago
Biotricity, Inc. (OTC:BTCY) Q2 2025 Earnings Conference Call November 15, 2024 4:30 PM ET Company Participants Dr. Waqaas Al-Siddiq - Founder and CEO John Ayanoglou - Chief Financial Officer Conference Call Participants Kevin Dede - H.C. Wainwright Operator Greetings.
Neutral
GlobeNewsWire
about 13 hours ago
REDWOOD CITY, Calif., Nov. 15, 2024 (GLOBE NEWSWIRE) -- Biotricity Inc.  (OTCQB: BTCY) (“Biotricity” or the “Company”), a Technology-as-a-Service (TaaS) company operating in the remote cardiac monitor sector of consumer healthcare, today announced its financial results for the second quarter of fiscal 2025 year and (unaudited) ended September 30, 2024.
Neutral
GlobeNewsWire
2 days ago
Company to announce improvements in Margins, Operational Efficiency, and a shift to positive Adjusted EBITDA REDWOOD CITY, Calif., Nov. 13, 2024 (GLOBE NEWSWIRE) -- Biotricity Inc.  (OTCQB:BTCY), an innovative Technology-as-a-Service (TaaS) company committed to redefining the landscape of the healthcare industry with state-of-the-art remote monitoring and diagnostic solutions, announced that it...
More Biotricity Inc News

Company Profile

Biotricity, Inc. is a medical technology company, which is focused on biometric data monitoring solutions. It also involves in delivering, remote monitoring solutions to the medical, healthcare, and consumer markets, with a focus on diagnostic and post-diagnostic solutions for lifestyle and chronic illnesses. The firm’s FDA-approved Bioflux MCT technology, is comprised of a monitoring device and software components, which is made available to the market, in order to assess, establish and develop sales processes, and market dynamics. The company was founded by Waqaas Al-Siddiq and Peter McGoldrick on August 29, 2012 and is headquartered in Redwood City, CA.

Head office United States
CEO Waqaas Al-Siddiq
Employees 55
Founded 2012
Website www.biotricity.com

Register for Free

StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.

The Apple stock at a glance with charts, current key metrics, news and stock analyses.
The Best Dividend Stocks in the Dividend Top Scorer list.
Stock Analyses of the Best Stocks Worldwide.
Start building wealth today